Tdap vaccine (tetanus, diphtheria, pertussis)

🧮 Dose calculator

Immunisation (vaccination) · Regimen source: FDA Boostrix · 2.2

• • ≥5 years after the last DTaP or Td; an additional dose ≥9 years after a previous Tdap. Pregnancy: one dose in the third trimester to protect the infant from pertussis. FDA Boostrix · 2.2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Boostrix · 8.1

  “Risk Summary All pregnancies have a risk of birth defect, loss, or other adverse outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Boostrix · 8.2

  “Data are not available to assess the effect of administration of BOOSTRIX on breastfed infants or on milk production/excretion.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Boostrix · 8.4

  “BOOSTRIX is not indicated for use in children aged younger than 10 years.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Boostrix · 8.5

  “In the initial‑dose clinical trials, 1,104 participants aged 65 years and older received BOOSTRIX; of these participants, 299 were aged 75 years and older.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.